Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy

SIMPLE SUMMARY: PTX3 could be a potential biomarker for PCa. To predict anyPCa and csPCa biomarker PTX3 was evaluated before PBx. Among the 455 eligible patients, PCa was detected in 49% and csPCa in 25%. PTX3 outperformed other variables in predicting both anyPCa and csPCa. Serum PTX3 levels might...

Descripción completa

Detalles Bibliográficos
Autores principales: Falagario, Ugo Giovanni, Busetto, Gian Maria, Netti, Giuseppe Stefano, Sanguedolce, Francesca, Selvaggio, Oscar, Infante, Barbara, Ranieri, Elena, Stallone, Giovanni, Carrieri, Giuseppe, Cormio, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036446/
https://www.ncbi.nlm.nih.gov/pubmed/33807333
http://dx.doi.org/10.3390/cancers13071611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036446/
https://www.ncbi.nlm.nih.gov/pubmed/33807333
http://dx.doi.org/10.3390/cancers13071611

Ejemplares similares